全文获取类型
收费全文 | 2356498篇 |
免费 | 175242篇 |
国内免费 | 5666篇 |
专业分类
耳鼻咽喉 | 30839篇 |
儿科学 | 76609篇 |
妇产科学 | 65485篇 |
基础医学 | 348490篇 |
口腔科学 | 65597篇 |
临床医学 | 227352篇 |
内科学 | 452766篇 |
皮肤病学 | 48676篇 |
神经病学 | 193658篇 |
特种医学 | 85842篇 |
外国民族医学 | 604篇 |
外科学 | 329146篇 |
综合类 | 51053篇 |
现状与发展 | 4篇 |
一般理论 | 1004篇 |
预防医学 | 201120篇 |
眼科学 | 52559篇 |
药学 | 173758篇 |
13篇 | |
中国医学 | 4831篇 |
肿瘤学 | 128000篇 |
出版年
2019年 | 19637篇 |
2018年 | 26830篇 |
2017年 | 20409篇 |
2016年 | 22213篇 |
2015年 | 25434篇 |
2014年 | 35294篇 |
2013年 | 54524篇 |
2012年 | 74406篇 |
2011年 | 79196篇 |
2010年 | 46003篇 |
2009年 | 43195篇 |
2008年 | 73284篇 |
2007年 | 78038篇 |
2006年 | 77722篇 |
2005年 | 75608篇 |
2004年 | 72419篇 |
2003年 | 69089篇 |
2002年 | 66932篇 |
2001年 | 102653篇 |
2000年 | 105314篇 |
1999年 | 88771篇 |
1998年 | 25649篇 |
1997年 | 23266篇 |
1996年 | 23251篇 |
1995年 | 22109篇 |
1994年 | 20650篇 |
1993年 | 19330篇 |
1992年 | 70893篇 |
1991年 | 69789篇 |
1990年 | 67677篇 |
1989年 | 64756篇 |
1988年 | 60018篇 |
1987年 | 58854篇 |
1986年 | 56146篇 |
1985年 | 53569篇 |
1984年 | 40501篇 |
1983年 | 35109篇 |
1982年 | 21115篇 |
1979年 | 37880篇 |
1978年 | 27479篇 |
1977年 | 22677篇 |
1976年 | 21783篇 |
1975年 | 22764篇 |
1974年 | 27833篇 |
1973年 | 27393篇 |
1972年 | 25577篇 |
1971年 | 23895篇 |
1970年 | 22363篇 |
1969年 | 20749篇 |
1968年 | 19575篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
A 37-year-old male with history of alcohol abuse presented to us with nausea, vomiting, and abdominal pain with ascites. He was diagnosed with alcoholic liver disease with coagulopathy and pancreatitis. During hospitalization, the patient developed intra-abdominal hemorrhage. He was treated with platelets, packed red blood cells and fresh frozen plasma without any improvement. Following this he was treated with activated recombinant factor VII (90 microg/kg), which resulted in normalization of the prothrombin time and the activated partial thromboplastin time and stabilization of hematocrit within a few hours. We review the current literature on the approved and off-label use of activated recombinant factor VII. 相似文献
995.
Niall C McGonigle J Mark Jones Pushpinder Sidhu Simon W MacGowan 《Journal of cardiothoracic surgery》2007,2(1):24-6
Background
Long-term survival for combined aortic and mitral valve replacement appears to be determined by the mitral valve prosthesis from our previous studies. This 21-year retrospective study assess long-term outcome and durability of aortic valve replacement (AVR) with either concomitant mitral valve replacement (MVR) or mitral valve repair (MVrep). We consider only a single mechanical prosthesis. 相似文献996.
Marta Méndez-López Magdalena Méndez Fernando Sánchez-Patán Isabel Casado Maria-Angeles Aller Laudino López Maria-Teresa Corcuera Maria-Jose Alonso Maria-Paz Nava Jaime Arias Jorge-Luis Arias 《Journal of gastrointestinal surgery》2007,11(2):187-194
To obtain a new model of chronic portal hypertension in the rat, two classical methods to produce portal hypertension, partial portal vein ligation and the oral administration of thioacetamide (TAA), have been combined. Male Wistar rats were divided into four groups: 1 (control; n?=?10), 2 [triple partial portal vein ligation (TPVL); n?=?9], 3 (TAA; n?=?11), and 4 (TPVL plus TAA; n?=?9). After 3 months, portal pressure, types of portosystemic collateral circulation, laboratory hepatic function tests (aspartate aminotransferase, alanine aminotransferase, bilirubin, alkaline phosphatase, and gamma-glutamyl transpeptidase) and liver histology were studied. The animals belonging to group 2 (TPVL) developed extrahepatic portosystemic collateral circulation, associated with mesenteric venous vasculopathy without hepatic destructurization or portal hypertension. Animals from group 3 (TAA) developed cirrhosis and portal hypertension but not extrahepatic portosystemic collateral circulation, or mesenteric venous vasculopathy. Finally, the animals from group 4 (TPVL?+?TAA) developed cirrhosis, portal hypertension, portosystemic collateral circulation, and mesenteric venous vasculopathy. The association of TPVL and TAA can be used to obtain a model of chronic portal hypertension in the rat that includes all the alterations that patients with hepatic cirrhosis usually have. This could, therefore, prove to be a useful tool to study the pathophysiological mechanisms involved in these alterations. 相似文献
997.
PURPOSE: The beneficial role of elective neck dissection (END) in the management of high-risk cutaneous squamous cell carcinoma (CSCC) of the head and neck remains unproven. Some surgical specialists suggest that END may be beneficial for patients with clinically node-negative (N0) high-risk CSCC, but there are few data to support this claim. We reviewed the available literature regarding the use of END in the management of both CSCC and head and neck SCC (HNSCC). METHODOLOGY: The available medical literature pertaining to END in both CSCC and HNSCC was reviewed using PubMed and Ovid Medline searches. RESULTS: Many surgical specialists recommend that END be routinely performed in patients with N0 HNSCC when the risk of occult metastases is estimated to exceed 20%; however, patients who undergo END have no proven survival benefit over those who are initially staged as N0 and undergo therapeutic neck dissection (TND) after the development of apparent regional disease. There is a lack of data regarding the proper management of regional nodal basins in patients with N0 CSCC. In the absence of evidence-based data, the cutaneous surgeon must rely on clinical judgment to guide the management of patients with N0 high-risk CSCC of the head and neck. CONCLUSIONS: Appropriate work-up for occult nodal disease may occasionally be warranted in patients with high-risk CSCC. END may play a role in only a very limited number of patients with high-risk CSCC. 相似文献
998.
999.
L. Malet 《Annales médico-psychologiques》2007,165(6):443-448
Psychological support is an essential concern in the management of alcohol misuses. Motivation and readiness to change are key factors of the evolution. They have to be in the centre of the patient-doctor relation. Regular evaluation is a part of a step by step therapeutic strategy. 相似文献
1000.
We conducted a double blind controlled trial in 28 Duchenne muscular dystrophy (DMD) patients with Deflazacort (DF), an oxazoline derivative of prednisolone which reduces its side-effects. Myometric muscle strength measurements, Scott Score and timed tests showed statistically significant improvement for the treated group (P less than 0.05). Side-effects after 9 months of treatment included mild cushingoid appearance in four patients (28%) and moderate in only one (7%), increased appetite in seven (50%), increased body hair in four (28%), irritability and hyperactivity in three (21%). Increased body weight was not prominent and was controlled with dietary measures. No patient had to be withdrawn from medication. More research and long-term follow-up are needed in order to establish the mechanism of improvement and the consequences of long-term steroid administration in DMD. In this regard DF appears as an alternative to prednisone preserving its benefits but with fewer side-effects. 相似文献